Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Emergent Biosolutions: Q4 Earnings Snapshot
Emergent Biosolutions: Q4 Earnings Snapshot
Associated Press Finance
Fri, February 27, 2026 at 6:58 AM GMT+9 1 min read
In this article:
EBS
+0.82%
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Thursday reported a loss of $54.6 million in its fourth quarter.
On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.04. Losses, adjusted for non-recurring costs, came to 43 cents per share.
The biopharmaceutical company posted revenue of $148.7 million in the period.
For the year, the company reported profit of $52.6 million, or 93 cents per share. Revenue was reported as $742.9 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on EBS at
Terms and Privacy Policy
Privacy Dashboard
More Info